Otoprotection Mechanisms Against Oxidative Stress Caused by Cisplatin

Abstract

Introduction Cisplatin damages the auditory system and is related to the generation of free radicals. Glutathione peroxidase is an endogenous free radicals remover.

Objective To investigate the mechanisms involved in otoprotection by N-acetylcysteine through the expression of glutathione peroxidase in outer hair cells from rats treated with cisplatin.

Methods Male Wistar rats were intraperitoneally injected with cisplatin (8 mg/Kg) and/or received oral administration by gavage of N-acetylcysteine (300 mg/Kg) for 3 consecutive days. On the 4^th day, the animals were euthanized and beheaded. The tympanic bullae were removed and prepared for scanning electron microscopy and immunofluorescence.

Results Among the groups exposed to ototoxic doses of cisplatin, there was an increase in glutathione peroxidase immunostaining in two groups, the one exposed to cisplatin alone, and the group exposed to both cisplatin and N-acetylcysteine.

Conclusion The expression of glutathione peroxidase in the outer hair cells of rats exposed to cisplatin showed the synthesis of this enzyme under cellular toxicity conditions.

Keywords

cisplatin - toxicity - free radicals - cochlea - oxidative stress

• References

• 1 Riga MG, Chelis L, Kakolyris S. , et al. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol 2013; 36 (01) 1-6
• 2 Somani SM, Husain K, Jagannathan R, Rybak LP. Amelioration of cisplatin-induced oto and nephrotoxicity by protective agents. Ann Neurosci 2001; 8: 101-113
• 3 Rybak LP. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg 2007; 15 (05) 364-369
• 4 McKeage MJ. Comparative adverse effect profiles of platinum drugs. Drug Saf 1995; 13 (04) 228-244
• 5 Casares C, Ramírez-Camacho R, Trinidad A, Roldán A, Jorge E, García-Berrocal JR. Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal models. Eur Arch Otorhinolaryngol 2012; 269 (12) 2455-2459
• 6 Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 2005; 314 (03) 1052-1058
• 7 Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993; 103 (4 Pt 2): 1-52
• 8 van Ruijven MWM, de Groot JCMJ, Klis SFL, Smoorenburg GF. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 2005; a; 205 (1-2): 241-248
• 9 Rybak LP, Husain K, Morris C, Whitworth C, Somani S. Effect of protective agents against cisplatin ototoxicity. Am J Otol 2000; 21 (04) 513-520
• 10 Campbell KCM, Kalkanis J, Glatz R. Ototoxicity: mechanisms, protective agents and monitoring. Curr Opin Otol Head Neck Surg 2000; 8: 436-440
• 11 Feghali JG, Liu W, Van De Water TR. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001; 111 (07) 1147-1155
• 12 Rybak LP, Mukherjea D, Jajoo S, Ramkumar V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 2009; 219 (03) 177-186
• 13 Holdiness MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 1991; 20 (02) 123-134
• 14 Neuwelt EA, Pagel MA, Hasler BP, Deloughery TG, Muldoon LL. Therapeutic efficacy of aortic administration of Nacetylcysteine against bone marrow toxicity after intracarotid administration of alkylator, with or without glutathione depletion in a rat model. Cancer Res 2001; 61: 7868-7874
• 15 Strayer DS, Rubin E. Cell adaptation, cell injury and cell death. In: Rubin R, Strauer DS. Rubin's Pathology: clinicopathologic foundations of medicine, 6th edn. Philadelphia: Lippincott Williams & Wilkins; 2012: 01-46
• 16 Jero J, Coling DE, Lalwani AK. The use of Preyer's reflex in evaluation of hearing in mice. Acta Otolaryngol 2001; 121 (05) 585-589
• 17 De Freitas MR, Figueiredo AA, Brito GAC. , et al. The role of apoptosis in cisplatin-induced ototoxicity in rats. Rev Bras Otorrinolaringol (Engl Ed) 2009; 75 (05) 745-752
• 18 Hyppolito MA, Oliveira JAA, Rossato M, Holanda F. Cisplatin ototoxicity and otoprotetor to cilliated cells by ginkgo biloba extract: anatomic and eletrophisiologic study. Rev Bras Otorrinolaringol (Engl Ed) 2003; 69 (04) 504-511
• 19 Hyppolito MA, de Oliveira AA, Lessa RM, Rossato M. [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy]. Rev Bras Otorrinolaringol (Engl Ed) 2005; 71 (03) 268-273
• 20 Gutteridge JM, Halliwell B. Antioxidants: Molecules, medicines, and myths. Biochem Biophys Res Commun 2010; 393 (04) 561-564
• 21 Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today 2005; 10 (19) 1313-1321
• 22 Wu YJ, Muldoon LL, Neuwelt EA. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 2005; 312 (02) 424-431
• 23 Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004; 193 (1-2): 25-30
• 24 Muldoon LL, Pagel MA, Kroll RA. , et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000; 6 (01) 309-315
• 25 Neuwelt EA, Pagel MA, Kraemer DF, Peterson DR, Muldoon LL. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model. J Pharmacol Exp Ther 2004; 309 (02) 594-599